Kilitch Drugs (India) Analysis
| KILITCH Stock | 307.45 2.60 0.84% |
Kilitch Drugs Limited is overvalued with Real Value of 275.94 and Hype Value of 309.73. The main objective of Kilitch Drugs stock analysis is to determine its intrinsic value, which is an estimate of what Kilitch Drugs Limited is worth, separate from its market price. There are two main types of Kilitch Drugs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Kilitch Drugs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Kilitch Drugs' stock to identify patterns and trends that may indicate its future price movements.
The Kilitch Drugs stock is traded in India on National Stock Exchange of India, with the market opening at 09:15:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in India. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Kilitch Drugs' ongoing operational relationships across important fundamental and technical indicators.
Kilitch |
Kilitch Stock Analysis Notes
About 75.0% of the company outstanding shares are owned by corporate insiders. The book value of Kilitch Drugs was now reported as 109.62. The company recorded earning per share (EPS) of 10.27. Kilitch Drugs Limited last dividend was issued on the 20th of September 2019. To find out more about Kilitch Drugs Limited contact the company at 91 22 6121 4100 or learn more at https://www.kilitch.com.Kilitch Drugs Quarterly Total Revenue |
|
Kilitch Drugs Limited Investment Alerts
| Kilitch Drugs generated a negative expected return over the last 90 days | |
| Kilitch Drugs is unlikely to experience financial distress in the next 2 years | |
| Kilitch Drugs Limited has accumulated about 1.34 M in cash with (56.69 M) of positive cash flow from operations. | |
| Roughly 75.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Kilitch Drugs Standalone September 2024 Net Sales at Rs 45.35 crore, up 43.63 percent Y-o-Y - Moneycontrol |
Kilitch Drugs Thematic Classifications
In addition to having Kilitch Drugs stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Kilitch Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kilitch Drugs's market, we take the total number of its shares issued and multiply it by Kilitch Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Kilitch Profitablity
Kilitch Drugs' profitability indicators refer to fundamental financial ratios that showcase Kilitch Drugs' ability to generate income relative to its revenue or operating costs. If, let's say, Kilitch Drugs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Kilitch Drugs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Kilitch Drugs' profitability requires more research than a typical breakdown of Kilitch Drugs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Management Efficiency
Kilitch Drugs Limited has return on total asset (ROA) of 0.0566 % which means that it generated a profit of $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0832 %, meaning that it generated $0.0832 on every $100 dollars invested by stockholders. Kilitch Drugs' management efficiency ratios could be used to measure how well Kilitch Drugs manages its routine affairs as well as how well it operates its assets and liabilities. The current Total Assets is estimated to decrease to about 1.7 B. The current Non Current Assets Total is estimated to decrease to about 749.4 MUnderstanding the operational decisions made by Kilitch Drugs management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin 0.0241 | Profit Margin 0.0832 | Beta 0.282 | Return On Assets 0.0566 | Return On Equity 0.0832 |
Technical Drivers
As of the 26th of November, Kilitch Drugs secures the Mean Deviation of 1.69, standard deviation of 2.68, and Risk Adjusted Performance of (0.02). Kilitch Drugs Limited technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Kilitch Drugs Limited Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Kilitch Drugs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Kilitch Drugs Limited. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Kilitch Drugs Outstanding Bonds
Kilitch Drugs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kilitch Drugs Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kilitch bonds can be classified according to their maturity, which is the date when Kilitch Drugs Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Kilitch Drugs Predictive Daily Indicators
Kilitch Drugs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kilitch Drugs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0457 | |||
| Daily Balance Of Power | (0.18) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 312.4 | |||
| Day Typical Price | 310.75 | |||
| Market Facilitation Index | 14.6 | |||
| Price Action Indicator | (6.25) | |||
| Period Momentum Indicator | (2.60) |
Kilitch Drugs Forecast Models
Kilitch Drugs' time-series forecasting models are one of many Kilitch Drugs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kilitch Drugs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Kilitch Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Kilitch Drugs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kilitch shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kilitch Drugs. By using and applying Kilitch Stock analysis, traders can create a robust methodology for identifying Kilitch entry and exit points for their positions.
Kilitch Drugs is entity of India. It is traded as Stock on NSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kilitch Drugs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Complementary Tools for Kilitch Stock analysis
When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |